Page last updated: 2024-08-25

rosiglitazone and trinitrobenzenesulfonic acid

rosiglitazone has been researched along with trinitrobenzenesulfonic acid in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (60.00)29.6817
2010's2 (40.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Auwerx, J; Chambon, P; Colombel, JF; Derijard, B; Desreumaux, P; Desvergne, B; Dubuquoy, L; Englaro, W; Leibowitz, MD; Nutten, S; Peuchmaur, M; Schoonjans, K; Wahli, W1
Benight, N; Denson, LA; Frank, SJ; Han, X; Loesch, K; Osuntokun, B1
de la Lastra, CA; Martín, AR; Sánchez-Hidalgo, M; Villegas, I1
Da Silva, S; Keita, ÅV; Mattson, JP; Mohlin, S; Påhlman, I; Påhlman, S; Söderholm, JD; Theodorou, V1
Ge, S; Qian, J; Shao, Z; Wang, J; Wang, L; Wang, W; Xie, Q; Zhang, C; Zhou, C; Zuo, L1

Other Studies

5 other study(ies) available for rosiglitazone and trinitrobenzenesulfonic acid

ArticleYear
Attenuation of colon inflammation through activators of the retinoid X receptor (RXR)/peroxisome proliferator-activated receptor gamma (PPARgamma) heterodimer. A basis for new therapeutic strategies.
    The Journal of experimental medicine, 2001, Apr-02, Volume: 193, Issue:7

    Topics: Animals; Colitis; Dimerization; Drug Synergism; Mice; Mice, Mutant Strains; Receptors, Cytoplasmic and Nuclear; Receptors, Retinoic Acid; Retinoid X Receptors; Rosiglitazone; Tetrahydronaphthalenes; Thiazoles; Thiazolidinediones; Transcription Factors; Transcriptional Activation; Trinitrobenzenesulfonic Acid

2001
Signal transducer and activator of transcription 5b promotes mucosal tolerance in pediatric Crohn's disease and murine colitis.
    The American journal of pathology, 2006, Volume: 169, Issue:6

    Topics: Animals; Carrier Proteins; Child; Colitis; Colon; Crohn Disease; Epithelial Cells; Female; Genetic Predisposition to Disease; Humans; Hypoglycemic Agents; Intestinal Mucosa; Male; Mice; Mice, Inbred C57BL; Mucous Membrane; NF-kappa B; PPAR gamma; Rosiglitazone; Signal Transduction; STAT5 Transcription Factor; Thiazolidinediones; Trinitrobenzenesulfonic Acid

2006
Rosiglitazone, a PPARgamma ligand, modulates signal transduction pathways during the development of acute TNBS-induced colitis in rats.
    European journal of pharmacology, 2007, May-21, Volume: 562, Issue:3

    Topics: Acute Disease; Animals; Apoptosis; Blotting, Western; Colitis, Ulcerative; Cyclooxygenase 1; Cyclooxygenase 2; Cytokines; Dinoprostone; Hypoglycemic Agents; Immunoblotting; Inflammation; Male; Mitogen-Activated Protein Kinases; Neutrophils; p38 Mitogen-Activated Protein Kinases; Peroxidase; PPAR gamma; Rats; Rats, Wistar; Rosiglitazone; Signal Transduction; Thiazolidinediones; Transcription Factor RelA; Trinitrobenzenesulfonic Acid; Tumor Necrosis Factor-alpha

2007
A Novel Topical PPARγ Agonist Induces PPARγ Activity in Ulcerative Colitis Mucosa and Prevents and Reverses Inflammation in Induced Colitis Models.
    Inflammatory bowel diseases, 2018, 03-19, Volume: 24, Issue:4

    Topics: Adult; Aged; Animals; Colitis; Colitis, Ulcerative; Colon; Cytokines; Dextran Sulfate; Female; Humans; Intestinal Mucosa; Male; Mice, Inbred BALB C; Middle Aged; Perilipin-2; Peroxidase; PPAR gamma; Rosiglitazone; Trinitrobenzenesulfonic Acid

2018
[Rosiglitazone ameliorates TNBS-induced colitis in mice by inhibiting inflammation of the mesenteric adipose tissues].
    Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology, 2018, Volume: 34, Issue:9

    Topics: Adipose Tissue; Animals; Colitis; Cytokines; Inflammation; Male; Mice; Mice, Inbred BALB C; NF-kappa B; Rats; Rosiglitazone; Trinitrobenzenesulfonic Acid

2018